Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05659576 · ClinicalTrials.gov registry record · Phase 2
Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation
A Phase 2 study of Radiation Esophagitis, sponsored by Memorial Sloan Kettering Cancer Center.
- Active
- Registry status
- Phase 2
- Development phase
- 142
- Enrollment target
- 7
- Study locations
NCT05659576 is a Phase 2 study of Radiation Esophagitis that is active but no longer recruiting, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 142 participants. The trial reports 7 study locations across 2 states.
The verdict
NCT05659576, a Phase 2 study of Radiation Esophagitis, is active but no longer recruiting, sponsored by Memorial Sloan Kettering Cancer Center.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 2
- Development phase
- 142 participants
- Enrollment target
- 7
- Study locations
Study Summary
The purpose of the study is to explore options for preventing and reducing symptoms of radiation esophagitis (RE). The researchers will also look what symptoms participants experience, and whether there are differences in weight loss in participants.
Conditions Studied
Interventions
- OTHER Usual Care
- DRUG Sucralfate
- OTHER One consent
- OTHER Two consent
Study Locations (7)
New York
- Memorial Sloan Kettering Suffolk-Commack (All Protocol Activities ) - Commack
- Memorial Sloan Kettering Westchester (All Protocol Activities) - Harrison
- Memorial Sloan Kettering Cancer Center (All Protocol Activities) - New York
- Memorial Sloan Kettering Nassau (All Protocol Activities) - Uniondale
New Jersey
- Memorial Sloan Kettering Cancer Center Basking Ridge (All Protocol Activities) - Basking Ridge
- Memorial Sloan Kettering Monmouth (All Protocol Activities) - Middletown
- Memorial Sloan Kettering Bergen (All Protocol Activities) - Montvale
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 142 participants |
| Start Date | 2022-12-13 |
| Est. Completion | 2026-12 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05659576
The ClinicalTrials.gov registry entry for NCT05659576 describes a study currently listed as active not recruiting, categorized as Phase 2. The registered enrollment target is 142 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Radiation Esophagitis appearing as the primary indexed condition, and to 4 interventions - of which Usual Care is the first listed.
NCT05659576 reports 7 study locations spanning 2 distinct geographic areas - top geographies include New York, New Jersey.
Frequently Asked Questions
What is clinical trial NCT05659576 about?
NCT05659576 is a clinical study titled "Reducing Acute Upper Gastrointestinal Side-Effects of Thoracic Irradiation". The purpose of the study is to explore options for preventing and reducing symptoms of radiation esophagitis (RE). The researchers will also look what symptoms participants experience, and whether there are differences in weight loss in participants.
What is the current status of trial NCT05659576?
This trial is currently active not recruiting. It is a Phase 2 study. The enrollment target is 142 participants. The study started on 2022-12-13. Estimated completion is 2026-12.
What conditions does trial NCT05659576 study?
This clinical trial studies the following conditions: Radiation Esophagitis.
What interventions are being tested in trial NCT05659576?
The interventions under investigation include: Usual Care (OTHER), Sucralfate (DRUG), One consent (OTHER), Two consent (OTHER).
Who is sponsoring clinical trial NCT05659576?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05659576 being conducted?
This trial has 7 study locations across New Jersey, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Radiation Esophagitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.